AI could help match pancreatic cancer patients to the right chemo
NCT ID NCT06320717
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study collects blood and tumor samples from 100 people with pancreatic cancer who are about to receive standard chemotherapy before surgery. Researchers will use an artificial intelligence algorithm to analyze the tumor tissue and look for biomarkers that predict which treatment works best. The goal is to develop a tool that helps doctors personalize chemotherapy choices for future patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a test that helps doctors choose the most effective chemotherapy for each pancreatic cancer patient before surgery.
What could go wrong
This is an early observational study, not a treatment trial. The AI biomarker may not prove accurate enough to change clinical practice, and results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Good Samaritan University Hospital
RECRUITINGWest Islip, New York, 11795, United States
Contact Phone: •••-•••-••••
Contact
-
Roswell Park Comprehensive Cancer Center
RECRUITINGBuffalo, New York, 14263, United States